U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency

Patent 4695624 Issued on September 22, 1987. Estimated Expiration Date: Icon_subject April 4, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3759890

Carrier-bound protein prepared by reacting the protein with an acylating or alkylating compound having a carrier-bonding group and reacting the product with a carrier
Patent #: 3969287
Issued on: 07/13/1976
Inventor: Jaworek ,   et al.

Reactive derivatives of HS-group-containing polymers
Patent #: 4175073
Issued on: 11/20/1979
Inventor: Carlsson ,   et al.

Chemically modified endotoxin immunizing agent
Patent #: 4185090
Issued on: 01/22/1980
Inventor: McIntire

Peptide macromolecular complexes
Patent #: 4275000
Issued on: 06/23/1981
Inventor: Ross

Immunogenic polysaccharide-protein conjugates
Patent #: 4356170
Issued on: 10/26/1982
Inventor: Jennings ,   et al.

Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
Patent #: 4451446
Issued on: 05/29/1984
Inventor: Vandevelde ,   et al.

Coupled H. influenzae type B vaccine Patent #: 4459286
Issued on: 07/10/1984
Inventor: Hilleman ,   et al.

Inventors

Assignee

Application

No. 06/719678 filed on 04/04/1985

US Classes:

424/197.11, Conjugate or complex includes bacterium or component thereof or substance produced by said bacterium424/256.1, Hemophilus (e.g., Hemophilus influenzae, Hemophilus gallinarum, Hemophilus pleuropnemoniae, etc.)424/831, INVOLVING CAPSULAR POLYSACCHARIDE OF BACTERIUM (E.G., POLYRIBOSYL RIBITOL PHOSPHATE (PRP), ETC.)435/188, Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate530/395, Glycoprotein, e.g., mucins proteoglycans, etc.530/402, Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.530/403, Protein is identified as an antigen, e.g., immunogenic carriers, etc.530/404, Sulfur containing reactant530/405, Nitrogen containing reactant530/406, Oxygen containing reactant536/123, Plural diverse saccharides containing (e.g., hetero polysaccharides, etc.)536/123.1, Polysaccharides536/34, Phosphorus containing acid536/55.1Polysaccharides

Examiners

Primary: Kight, John
Assistant: Draper, Garnette D.

Attorney, Agent or Firm

International Classes

A61K 39/385 (20060101)
A61K 39/39 (20060101)
A61K 47/48 (20060101)
C07K 17/06 (20060101)
C07K 17/10 (20060101)
C07K 17/00 (20060101)
G01N 33/531 (20060101)
G01N 33/569 (20060101)

Abstract

Covalently modified bacterial polysaccharides and proteins; covalent conjugates of such polysaccharides linked by a bigeneric spacer, which permits proof of covalency and facilitates purification of conjugated materials, with immunogenic bacterial membrane or other proteins, which conjugates are useful components of bacterial vaccines; and methods of preparing such polysaccharides, proteins and conjugates and of confirming the covalency of the linkage between polysaccharides and proteins.

Other References

  • Chu et al., Inf. and Immunity, 40 (1), 1983, pp. 245-256
  • S. Marburg et al., J Am Chem Society, 108, 1986, 5282
  • Marburg et al., "Limitation of Cyonogen Bromide Activation of Polysaccharides", Merck Sharp and Dohme Res. Lab. publication
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?